175 related articles for article (PubMed ID: 6607952)
1. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
Davis AE; Harrison RA; Lachmann PJ
J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
[TBL] [Abstract][Full Text] [Related]
2. Third component of complement (C3): structural properties in relation to functions.
Bokisch VA; Dierich MP; Mūller-Eberhard HJ
Proc Natl Acad Sci U S A; 1975 Jun; 72(6):1989-93. PubMed ID: 1056006
[TBL] [Abstract][Full Text] [Related]
3. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
Becherer JD; Alsenz J; Esparza I; Hack CE; Lambris JD
Biochemistry; 1992 Feb; 31(6):1787-94. PubMed ID: 1371073
[TBL] [Abstract][Full Text] [Related]
4. Action of the C3b-inactivator on the cell-bound C3b.
Law SK; Fearon DT; Levine RP
J Immunol; 1979 Mar; 122(3):759-65. PubMed ID: 448074
[TBL] [Abstract][Full Text] [Related]
5. Receptor-binding sites on C3 and C3b.
Dierich MP; Bokisch VA
J Immunol; 1977 Jun; 118(6):2145-50. PubMed ID: 864256
[TBL] [Abstract][Full Text] [Related]
6. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
J Exp Med; 1977 Jul; 146(1):257-70. PubMed ID: 301546
[TBL] [Abstract][Full Text] [Related]
7. Interaction of soluble C3 fragments with guinea pig lymphocytes. Comparison of effects of C3a, C3b, C3c, and C3d on lymphokine production and lymphocyte proliferation.
Koopman WJ; Sandberg AL; Wahl SM; Mergenhagen SE
J Immunol; 1976 Jul; 117(1):331-6. PubMed ID: 932430
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of factor I by diisopropylfluorophosphate. Evidence of conformational changes in factor I induced by C3b and additional studies on the specificity of factor I.
Ekdahl KN; Nilsson UR; Nilsson B
J Immunol; 1990 Jun; 144(11):4269-74. PubMed ID: 2140392
[TBL] [Abstract][Full Text] [Related]
9. A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism.
Rodriguez E; Nan R; Li K; Gor J; Perkins SJ
J Biol Chem; 2015 Jan; 290(4):2334-50. PubMed ID: 25488663
[TBL] [Abstract][Full Text] [Related]
10. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.
Lambris JD; Ganu VS; Hirani S; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4235-9. PubMed ID: 2408276
[TBL] [Abstract][Full Text] [Related]
11. Kinetic studies on the fragmentation of the third component of complement (C3) by trypsin.
Minta JO; Man D; Movat HZ
J Immunol; 1977 Jun; 118(6):2192-8. PubMed ID: 864257
[TBL] [Abstract][Full Text] [Related]
12. Activation of rabbit C3: studies of the generation of cleavage products in vitro and of their metabolism in vivo.
Peake PW; Charlesworth JA; Pussell BA
Complement Inflamm; 1991; 8(5-6):261-70. PubMed ID: 1802545
[TBL] [Abstract][Full Text] [Related]
13. Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.
Nilsson B; Nilsson Ekdahl K; Avila D; Nilsson UR; Lambris JD
Biochem J; 1990 May; 268(1):55-61. PubMed ID: 1693076
[TBL] [Abstract][Full Text] [Related]
14. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).
Esparza I; Becherer JD; Alsenz J; De la Hera A; Lao Z; Tsoukas CD; Lambris JD
Eur J Immunol; 1991 Nov; 21(11):2829-38. PubMed ID: 1834472
[TBL] [Abstract][Full Text] [Related]
15. Formation of covalently linked C3-C3 dimers on IgG immune aggregates.
Barrio E; Antón LC; Marqués G; Sánchez A; Vivanco F
Eur J Immunol; 1991 Feb; 21(2):343-9. PubMed ID: 1999223
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of the third complement component of axolotl (Ambystoma mexicanum).
Avila D; Lambris JD
Comp Biochem Physiol B; 1990; 95(4):839-45. PubMed ID: 2344737
[TBL] [Abstract][Full Text] [Related]
17. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
18. Pattern of C3, iC3b, and C3d in patients hospitalized for acute asthma.
Lin RY; Caveliere LF; Lorenzana FG; Go EF; Altman KA
Ann Allergy; 1992 Apr; 68(4):324-30. PubMed ID: 1558328
[TBL] [Abstract][Full Text] [Related]
19. The apolipoprotein(a) moiety of lipoprotein(a) interacts with the complement activation fragment iC3b but does not functionally affect C3 activation or degradation.
Seifert PS; Roth I; Zioncheck TF
Atherosclerosis; 1992 Apr; 93(3):209-16. PubMed ID: 1534227
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of the complement regulating protein, beta 1H, in skin biopsies from patients with bullous pemphigoid.
Carlo JR; Gammon WR; Sams WM; Ruddy S
J Invest Dermatol; 1979 Dec; 73(6):551-3. PubMed ID: 390060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
